Heron soars after its painkiller agent reduces pain and opioid use post-surgery at Phase 3
March 20, 2018Manufacturing and Production, Research and Development heron therapeutics, opioid crisis, opioid epidemic, opioids, painkiller, pharma
Heron Therapeutics has been buoyed by the news that its painkiller agent HTX-011 met all of its primary and secondary …
Novartis steps into the medical marijuana business
March 20, 2018Manufacturing and Production, Sales and Marketing Medical marijuana, Novartis, Sandoz, biotech, drugs, pharma, pharmaceutical
Canada’s burgeoning medical marijuana industry has finally drawn in a big pharma player. Tilray, a producer of medical cannabis products, …
Regeneron’s Eylea smashes Phase 3 trial goal in diabetic retinopathy
March 20, 2018Manufacturing and Production, Research and Development Eylea, Regeneron, diabetes, pharma
Regeneron has confirmed that its vascular endothelial growth factor (VEGF) inhibitor injection Eylea (aflibercept) met its primary endpoint in a …
Roche’s immunotherapy improves PFS but unclear long-term benefit in lung cancer
March 20, 2018Manufacturing and Production, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq
Roche’ Tecentriq needs a big result in the immunotherapy space – it initially burst onto the scene as a third-to-market …
Vertex “astonished” by NHS England’s response to CF drug
March 20, 2018Manufacturing and Production, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical
Vertex has been battling to have its treatment, Orkambi, approved in the UK since 2016, when it was first rejected …
New Chief Science and Medical Officers for Gilead
March 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment
Gilead has announced that Dr Norbert Bischofberger, its Chief Scientific Officer (CSO), Executive Vice President of Research and Development and …
Male contraceptive pill hits safety goals
March 19, 2018Research and Development, Sales and Marketing biotech, drugs, male contraceptive, pharma, pharmaceutical
A male contraceptive pill may be edging closer to the market, after a new formulation was shown to be safe …
Working Life: Chris Round, Head of EMEA Region, Merck KGaA
March 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Round, MSD, Merck, Merck KGaA, Working Life, pharma
Merck KGaA’s Chris Round, Head of EMEA Region, spoke with Pharmafile.com to discuss his time at both the US and …
“Game-changer” stem cell transplant shows strength in multiple sclerosis
March 19, 2018Research and Development, Sales and Marketing Stem cells, multiple sclerosis, pharma
A new stem cell transplant is being hailed as a “game-changer” in the treatment of multiple sclerosis (MS) after an …
Lundbeck takes risk on Parkinson’s treatment, €905m on table
March 19, 2018Sales and Marketing Lundbeck, Parkinson's, biotech, drugs, pharma, pharmaceutical
CNS’ treatments are notoriously risky, especially those that are still at an early stage; however, Lundbeck has decided to take …
India’s Narcotics Control Bureau seizes 55,000 zolpidem tablets in drugs bust
March 19, 2018Manufacturing and Production, Sales and Marketing India, Narcotics Control Bureau, pharma
India’s drug agency, the Narcotics Control Bureau (NCB), has shut down an illegal trafficking racket in the country in a …
Pfizer to hang onto CEO, after 61% pay increase
March 19, 2018Medical Communications, Sales and Marketing Ian Read, Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer have given its Chief Executive Officer, Ian Read, a big boost to his pay packet, taking it to $27.9 …
Top Ten most popular articles on Pharmafile.com this week
March 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, BMS, Biocon, Martin Shkreli, Novartis, Right to try, US, pharma, top ten
Another week goes by, and we may have finally reached Spring here in the UK. Friday means its time for …
Rising levels of opioid prescriptions puts NHS under pressure
March 16, 2018Medical Communications NHS, biotech, drugs, opioid, pharma, pharmaceutical
It has been found that the number of prescriptions being written for opioid painkillers has risen from 10 million to …
NICE recommends Keytruda via CDF as first and only urothelial carcinoma immunotherapy
March 16, 2018Medical Communications, Sales and Marketing MSD, NICE, immunotherapy, keytruda, pharma
UK drugs watchdog NICE has published its finance guidance recommending the use of MSD’s Keytruda (pembrolizumab) on the NHS through …
Allergan navigating choppy waters, as shares rise and fall
March 16, 2018Medical Communications Allergan, Brent Saunders, biotech, drugs, pharma, pharmaceutical
By most measures Allergan has not had the most successful of years and one measure, in particular, is usually indicative …
Hearing drug failure puts biotech on brink
March 16, 2018Medical Communications, Research and Development Auris, biotech, drugs, pharma, pharmaceutical
Biotechs with few products in the portfolio are always at a risk should results come back flat, it often leads …
The need for flexible appraisal of rare disease medicines
March 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, feature, pharma, rare disease, rare diseases
Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal …
BMS restructure will transfer 90 jobs from NY state to Massachusetts and New Jersey
March 15, 2018Manufacturing and Production BMS, Bristol-Myers Squibb, Massachusetts, New York, new jersey, pharma
Bristol-Myers Squibb has announced plans to relocate around 90 roles from the state of New York to facilities in Massachusetts …
Solid Biosciences rocked by clinical hold, shareholders flee
March 15, 2018Research and Development Solid Biosciences, biotech, drugs, pharma, pharmaceutical
Solid Biosciences raised more than a few eyebrows when it only revealed a partial hold from the FDA stalling its …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
